Kentucky Sen. Rand Paul has proudly broadcasted his disdain for a host of very simple measures — vaccinations! putting a thin piece of fabric over your mouth! — shown to help mitigate the spread and severity of coronavirus, including its currently surging Delta variant. Only, as Paul disclosed Wednesday, his family seems to have been playing both sides of our current public health crisis, with his efforts to seemingly prolong the disease's impact across the country counteracted by his wife's sizeable investment in a company that makes medication used to treat serious COVID-19 infections.
According to a Senate disclosure form filed a whopping 16 months past the 45-day deadline for these sorts of investments, Paul revealed that his wife Kelly had purchased anywhere from $1,000 to $15,000 worth of stock in Gilead, the pharmaceutical makers of remdesivir, a broad-spectrum antiviral treatment that was considered an effective COVID-19 treatment method during the early days of the pandemic.
